← Back to Search

Endovascular Device

FDA Approved EVAR AAA Graft Systems for Abdominal Aortic Aneurysm (LEOPARD Trial)

N/A
Waitlist Available
Led By Christopher Kwolek, MD
Research Sponsored by Endologix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to five years
Awards & highlights

LEOPARD Trial Summary

This trial is comparing the Endologix AFX endovascular AAA system with anatomical fixation against other approved Endovascular systems with proximal fixation, to see which is better.

Eligible Conditions
  • Abdominal Aortic Aneurysm

LEOPARD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to five years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to five years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AIDS related complex
Secondary outcome measures
Loss of Neck Apposition as Measured by Length in mm
Number of AAA Related Secondary Procedures
Number of Adjunctive Procedures Necessitated During the Implant Procedure.
+5 more

LEOPARD Trial Design

2Treatment groups
Active Control
Group I: FDA Approved EVAR AAA Graft SystemsActive Control1 Intervention
Subjects randomized to receive the comparator AAA Endovascular Graft System for implantation to repair Abdominal Aortic Aneurysm via femoral access.
Group II: AFX EVAR AAA Graft SystemActive Control1 Intervention
Subjects randomized to receive the Endologix AFX Endovascular Graft System for implantation to repair Abdominal Aortic Aneurysm via femoral access.

Find a Location

Who is running the clinical trial?

EndologixLead Sponsor
22 Previous Clinical Trials
3,517 Total Patients Enrolled
Christopher Kwolek, MDPrincipal InvestigatorEndologix
4 Previous Clinical Trials
1,498 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices
2015. "Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02407457.
~45 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top